Nathan Sadler

Array ( [id] => 3014105 [patent_doc_number] => 05308834 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-03 [patent_title] => 'Treatment of endotoxin-associated shock and prevention thereof using a BPI protein' [patent_app_type] => 1 [patent_app_number] => 7/990662 [patent_app_country] => US [patent_app_date] => 1992-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 45 [patent_no_of_words] => 18459 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/308/05308834.pdf [firstpage_image] =>[orig_patent_app_number] => 990662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2890737 [patent_doc_number] => 05244658 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-14 [patent_title] => 'Biological inoculant effective against aphanomyces' [patent_app_type] => 1 [patent_app_number] => 7/989931 [patent_app_country] => US [patent_app_date] => 1992-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7428 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/244/05244658.pdf [firstpage_image] =>[orig_patent_app_number] => 989931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3087037 [patent_doc_number] => 05278142 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-11 [patent_title] => 'Systemic delivery of polypeptides through the eye' [patent_app_type] => 1 [patent_app_number] => 7/966877 [patent_app_country] => US [patent_app_date] => 1992-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 10477 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/278/05278142.pdf [firstpage_image] =>[orig_patent_app_number] => 966877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3050476 [patent_doc_number] => 05283236 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-01 [patent_title] => 'Systemic delivery of polypeptides through the eye' [patent_app_type] => 1 [patent_app_number] => 7/966706 [patent_app_country] => US [patent_app_date] => 1992-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 10492 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/283/05283236.pdf [firstpage_image] =>[orig_patent_app_number] => 966706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3009950 [patent_doc_number] => 05281577 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-25 [patent_title] => 'Inhibitor of the proliferation of herpes viruses and inhibitor of the recurrence of affections caused by their latent infection' [patent_app_type] => 1 [patent_app_number] => 7/962022 [patent_app_country] => US [patent_app_date] => 1992-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3407 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/281/05281577.pdf [firstpage_image] =>[orig_patent_app_number] => 962022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2971530 [patent_doc_number] => 05256412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-26 [patent_title] => 'Anti-HIV agent' [patent_app_type] => 1 [patent_app_number] => 7/930349 [patent_app_country] => US [patent_app_date] => 1992-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 5736 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/256/05256412.pdf [firstpage_image] =>[orig_patent_app_number] => 930349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3014070 [patent_doc_number] => 05308832 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-03 [patent_title] => 'Nutritional product for persons having a neurological injury' [patent_app_type] => 1 [patent_app_number] => 7/920087 [patent_app_country] => US [patent_app_date] => 1992-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8324 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/308/05308832.pdf [firstpage_image] =>[orig_patent_app_number] => 920087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2917532 [patent_doc_number] => 05200177 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-06 [patent_title] => 'Treatment of atopic disorders with gamma-interferon' [patent_app_type] => 1 [patent_app_number] => 7/912564 [patent_app_country] => US [patent_app_date] => 1992-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3477 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/200/05200177.pdf [firstpage_image] =>[orig_patent_app_number] => 912564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3040629 [patent_doc_number] => 05334380 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-02 [patent_title] => 'Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension' [patent_app_type] => 1 [patent_app_number] => 7/910868 [patent_app_country] => US [patent_app_date] => 1992-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 12843 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/334/05334380.pdf [firstpage_image] =>[orig_patent_app_number] => 910868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2958864 [patent_doc_number] => 05198420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-30 [patent_title] => 'Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome' [patent_app_type] => 1 [patent_app_number] => 7/913789 [patent_app_country] => US [patent_app_date] => 1992-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 7945 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/198/05198420.pdf [firstpage_image] =>[orig_patent_app_number] => 913789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3067712 [patent_doc_number] => 05336488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-09 [patent_title] => 'Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines' [patent_app_type] => 1 [patent_app_number] => 7/905969 [patent_app_country] => US [patent_app_date] => 1992-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 4972 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/336/05336488.pdf [firstpage_image] =>[orig_patent_app_number] => 905969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3094042 [patent_doc_number] => 05292724 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-08 [patent_title] => 'Intraocular anticoagulant including antithrombin III and method of administration' [patent_app_type] => 1 [patent_app_number] => 7/904506 [patent_app_country] => US [patent_app_date] => 1992-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2469 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/292/05292724.pdf [firstpage_image] =>[orig_patent_app_number] => 904506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3419842 [patent_doc_number] => 05478807 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-26 [patent_title] => 'Use of relaxin in the treatment of bradycardia' [patent_app_type] => 1 [patent_app_number] => 7/902637 [patent_app_country] => US [patent_app_date] => 1992-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 25 [patent_no_of_words] => 14003 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/478/05478807.pdf [firstpage_image] =>[orig_patent_app_number] => 902637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2934486 [patent_doc_number] => 05246920 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-21 [patent_title] => 'Treatment of hyperprolactinemia' [patent_app_type] => 1 [patent_app_number] => 7/898523 [patent_app_country] => US [patent_app_date] => 1992-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2816 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/246/05246920.pdf [firstpage_image] =>[orig_patent_app_number] => 898523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3095906 [patent_doc_number] => 05318958 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-07 [patent_title] => 'Amyloid precursor protein' [patent_app_type] => 1 [patent_app_number] => 7/890936 [patent_app_country] => US [patent_app_date] => 1992-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 5539 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/318/05318958.pdf [firstpage_image] =>[orig_patent_app_number] => 890936 [rel_patent_id] =>[rel_patent_doc_number] =>)